Community-level Monitoring of Antimicrobial Resistance following Mass Administration of Azithromycin to Reduce Child Mortality in Côte d’Ivoire: Results from Two Rounds of Surveillance
Gates Open Research · 02.06.2026 · 10 · 31
DOI: 10.12688/gatesopenres.16385.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gates Open Research, online erschienen am 02.06.2026. Verfasst von Lisa Dulli und 9 weiteren Autor:innen. Beteiligte Einrichtung: FHI 360, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Azithromycin, Anti-Bacterial Agents, Streptococcus pneumoniae, Drug Resistance, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation, Gates Foundation.
Abstract (Originalsprache)
Background
Mass Drug Administration (MDA) of azithromycin for the elimination of trachoma and, more recently, for the reduction of child mortality, are public health strategies shown, with mixed results, to contribute to the development of azithromycin resistance in treated communities. The objective of this study was to monitor bacterial resistance to azithromycin among children targeted by bi-annual MDA-azithromycin campaigns to improve child survival in eight high-mortality regions of Côte d’Ivoire.
Methods
Two rounds of cross-sectional surveys were carried out in targeted health districts using a 2-stage cluster sampling to select representative samples of children aged 1–11 months at the time of the most recent MDA. Parents/primary caregivers were interviewed about the child’s overall health and exposure to MDA, azithromycin, and other antibiotics. Nasopharyngeal swabs were collected to estimate the carriage of Streptococcus pneumoniae and the prevalence of macrolide-resistant S. pneumoniae using erythromycin as a proxy for azithromycin. Phenotypic and genotypic determinants of macrolide resistance were tested in a subsample of resistant bacteria using duplex PCR.
Results
A total of 606 and 692 eligible children in 2022 and 2023, respectively, were included in the analyses. Prevalence of S. pneumoniae carriage was 28.8% (95%CI:22.4, 35.3) in 2022 and 30.8% (95%CI:25.0, 36.7) in 2023 (p=0.6506). There was no statistically significant difference in the prevalence of erythromycin-resistant S. pneumoniae between the two surveys (32.8% (95%CI:25.3, 40.2) versus 26.2% (95%CI:19.8, 32.6); p=0.0537). The majority of macrolide resistance phenotypes in both surveys were predominantly constitutive macrolide-lincosamide-streptogramin B (MLSb), carried by erm(B)-type genes.
Conclusions
Community-level bacterial resistance to azithromycin in our samples of S. pneumoniae did not increase significantly between the two surveys. As countries weigh the benefits and costs to implement MDA azithromycin, more is needed to interpret the relevancy and clinical impact of observed antimicrobial resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- FHI 360, Durham, North Carolina, USA.
- Institut Pasteur de Cote d'Ivoire, Abidjan, Cote d'Ivoire.
- FHI 360, Abidjan, Cote d'Ivoire.
- Universite Peleforo Gon Coulibaly, Korhogo, Cote d'Ivoire.
- PnP Ahead LLC, Seattle, Washington, USA.
ORCID-Profile: Lisa Dulli
Förderung
- Bill & Melinda Gates Foundation
- Gates Foundation
Zitieren
APA
Dulli, L., Gbonon, V., Touré, F., Touré, D., Guédé Kipré, B., Nelson, F., Murray, K., Evens, E., Dosso, M., & Sadate-Ngatchou, P. (2026). Community-level Monitoring of Antimicrobial Resistance following Mass Administration of Azithromycin to Reduce Child Mortality in Côte d’Ivoire: Results from Two Rounds of Surveillance. Gates Open Research, 10, 31. https://doi.org/10.12688/gatesopenres.16385.1
Vancouver
Dulli L, Gbonon V, Touré F, Touré D, Guédé Kipré B, Nelson F, et al. Community-level Monitoring of Antimicrobial Resistance following Mass Administration of Azithromycin to Reduce Child Mortality in Côte d’Ivoire: Results from Two Rounds of Surveillance. Gates Open Research. 2026;10:31. doi:10.12688/gatesopenres.16385.1
BibTeX
@article{Dulli2026,
author = {Dulli, Lisa and Gbonon, Valérie and Touré, Fatoumata and Touré, Daouda and Guédé Kipré, Bertin and Nelson, Felicity and Murray, Kate and Evens, Emily and Dosso, Mireille and Sadate-Ngatchou, Pat},
title = {Community-level Monitoring of Antimicrobial Resistance following Mass Administration of Azithromycin to Reduce Child Mortality in Côte d’Ivoire: Results from Two Rounds of Surveillance},
journal = {Gates Open Research},
year = {2026},
volume = {10},
pages = {31},
doi = {10.12688/gatesopenres.16385.1}
}
EUVIMED